# Mailed FIT Outreach 2022

> **NCT05341622** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 5460 (actual)

## Conditions studied

- Colorectal Cancer
- Colon Cancer

## Interventions

- **BEHAVIORAL:** Differentiated Box
- **BEHAVIORAL:** Standard Mail
- **BEHAVIORAL:** Text
- **BEHAVIORAL:** No Text
- **BEHAVIORAL:** Reminder
- **BEHAVIORAL:** No Reminder

## Key facts

- **NCT ID:** NCT05341622
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-27
- **Primary completion:** 2022-10-13
- **Final completion:** 2022-12-13
- **Target enrollment:** 5460 (ACTUAL)
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05341622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05341622, "Mailed FIT Outreach 2022". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05341622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*